Liu, S., An, L., Yin, Z., Lin, Y., Ling, Z., Deng, B., . . . Tong, C. Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationLiu, Shuangyou, et al. Five-year Outcomes of CD19 Followed by CD22 Chimeric Antigen Receptor T-cell Therapy in B-cell Acute Lymphoblastic Leukemia Patients Who Relapsed After Allo-transplantation. Ferrata Storti Foundation.
MLA (9th ed.) CitationLiu, Shuangyou, et al. Five-year Outcomes of CD19 Followed by CD22 Chimeric Antigen Receptor T-cell Therapy in B-cell Acute Lymphoblastic Leukemia Patients Who Relapsed After Allo-transplantation. Ferrata Storti Foundation.
Warning: These citations may not always be 100% accurate.